JLE

Epileptic Disorders

MENU

Nanotechnology may provide hope for patients with glucose transporter type 1 deficiency syndrome Volume 24, issue 3, June 2022

Figure 1.

Strategies that could be exploited for glucose delivery by nanoparticles to the brain.